Our Work · Working GroupS
Clinical Trial Modernization
This working group is addressing the evolving landscape of clinical trial conduct in the modern era through proof-of-concept projects, publications, and more.
Modernizing clinical research through responsible innovation and collaboration
Finding a modern approach
As tools such as artificial intelligence advance, clinician scientists have new opportunities to modernize clinical research. Responsible implementation requires collaboration across multiple stakeholder groups. H&VC’s Clinical Trial Modernization Working Group is addressing this evolving landscape through publications, proof-of-concept projects, and educational materials designed to streamline all stages of clinical research and support improved patient outcomes.
Leadership
Meet the group’s leadership
Cardiovascular Research Foundation / St. Francis Hospital, New York, NY / Roslyn, NY
Cardiovascular Research Foundation, New York, NY
Duke Clinical Research Institute, Durham, NC
Beth Israel Deaconess Medical Center, Boston, MA
Learn more from this working group
Publication · 2026
Clinical Trial Modernization · Tricuspid
In this preplanned Tricuspid Valve Academic Research Consortium-2 (TVARC-2) consensus document, we seek to utilize the definitions and principles described in TVARC-1 to create Chapter 2. Specifically, TVARC-2 proposes trial designs and endpoints to inform future transcatheter tricuspid valve intervention investigation.
Podcast · 17 min
Video · 17 min
Clinical Trial Modernization
Modernizing the Data Infrastructure for Clinical Research
Michael Mack and Amy Abernathy discuss how to streamline research and accelerate timelines in order to provide timely care.
Long-Term Follow-Up of Patients with Heart Valve Devices Workshop
June 21, 2024
Course Directors: Changfu Wu, Rosann White
Presentation: 12:05 PM – 12:10 PM
Overview of FDA-Mandated Long-Term Postapproval Studies for Heart Valve Devices
Lisa Plummer, RN, MSN
Co-sponsored by
Watch the video
Explore other working groups
Find out what other H&VC working groups have developed.
Working group
A global group of leading experts working to advance knowledge and share best practices in the prevention and treatment of rheumatic heart disease.
Explore the group
Working group
A number of ongoing efforts to build knowledge, develop consensus, and ignite innovation in congenital, adult congenital, and pediatric heart disease.
Explore the group